Skip to main content

Find Clinical Trials

Home
Conditions
Urinary Bladder Neoplasms

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

103 public trials 42 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Not yet recruiting

Efficacy of Gemcitabine Submucosal Injection for Preventing Recurrence in Intermediate- and High-Risk Non-Muscle-Invasive Bladder Cancer: A Randomized Trial

NCT07198451

Conditions: Carcinoma, Disease Attributes, Female Urogenital Diseases, +17 more
Locations: Not specified

View Trial Details

Not yet recruiting

RC48 in Combination With Radiotherapy for HER2-Expressing NMIBC Patients

NCT07100184

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC.

NCT07064863

Conditions: Bladder (Urothelial, Transitional Cell) Cancer, Carcinoma, Female Urogenital Diseases, +16 more
Locations: Kingston Health Sciences Center Kingston, Ontario, Canada

View Trial Details

Not yet recruiting

Observational Clinical Study on High - Risk NMIBC Patients Choosing Trimodality Bladder - Sparing Therapy

NCT07053748

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

T-Control® Safety for Cytostatics Management

NCT06678633

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Clinical Trial Evaluating the Efficacy and Safety of Disitamab Vedotin Plus Tislelizumab Combined with Re-TURBT in the Treatment of HER-2-high Expression(2+-3+) Non-muscle Invasive Bladder Cancer At High-risk and Very High-risk.

NCT06630871

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Fujian Medical University Union Hospital Fuzhou, Fujian, China

View Trial Details

Not yet recruiting

SHR-1501 Combined With SHR-2005 for High-Risk Non-Muscle Invasive Bladder Cancer Which is Not Completely Resectable by TURBt

NCT06588179

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer

NCT06327932

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

RC48-ADC in Adjuvant/Salvage Treatment of HER2 Positive Non-muscle-invasive Bladder Cancer

NCT05996952

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Active, not recruiting

A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

NCT06211764

Conditions: Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Arkansas Urology Little Rock, Arkansas, United States

Genesis Research LLC 1 Los Alamitos, California, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

University of California Irvine Medical Center Orange, California, United States

View all 123 locations

View Trial Details